These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10650815)

  • 61. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
    Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
    Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
    [TBL] [Abstract][Full Text] [Related]  

  • 62. p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.
    Yang W; Qi Q; Zhang H; Xu W; Chen Z; Wang L; Wang Y; Dong X; Jiao H; Huo Z
    Ann Surg Oncol; 2010 May; 17(5):1453-8. PubMed ID: 20112071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
    Nakamura T; Hayashi K; Ota M; Ide H; Takasaki K; Mitsuhashi M
    Dis Esophagus; 2004; 17(4):315-21. PubMed ID: 15569370
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients.
    Lam KY; Law S; Tin L; Tung PH; Wong J
    Am J Gastroenterol; 1999 Aug; 94(8):2060-8. PubMed ID: 10445528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alterations in the expression of alpha6beta4 integrin and p21/WAF1/Cip1 in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
    Khare L; Sabourin CL; DeYoung BR; Wagner BA; Stoner GD
    Mol Carcinog; 1998 Mar; 21(3):185-93. PubMed ID: 9537650
    [TBL] [Abstract][Full Text] [Related]  

  • 66. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
    Schwandner O; Bruch HP; Broll R
    Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
    Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
    Naitoh H; Shibata J; Kawaguchi A; Kodama M; Hattori T
    Am J Pathol; 1995 May; 146(5):1161-9. PubMed ID: 7747810
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma].
    Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S
    Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The prognostic role of apoptosis mediators in rectal adenocarcinoma.
    Seicean R; Crisan D; Boers JE; Mocan T; Seicean A; Funariu G; Ciuce C
    Hepatogastroenterology; 2011; 58(110-111):1490-4. PubMed ID: 21940317
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
    Bukholm IK; Nesland JM
    Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma.
    Liu XP; Kawauchi S; Oga A; Suehiro Y; Tsushimi K; Tsushimi M; Sasaki K
    Histopathology; 2001 Dec; 39(6):603-10. PubMed ID: 11903579
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Malignancy of colorectal cancer analyzed by expression of cyclin D1].
    Maeda K; Kang SM; Ogawa M; Chung YS; Onoda N; Nakata B; Nishiguchi Y; Ikehara T; Okuno M; Sowa M
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():259-62. PubMed ID: 9263512
    [TBL] [Abstract][Full Text] [Related]  

  • 74. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
    Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy.
    Costa MJ; Hansen CL; Walls JE; Scudder SA
    Hum Pathol; 1999 Jun; 30(6):640-7. PubMed ID: 10374771
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantitative analysis of the cyclin expression in human esophageal cancer cell lines.
    Fujii S; Tominaga O; Nagawa H; Tsuno N; Nita ME; Tsuruo T; Muto T
    J Exp Clin Cancer Res; 1998 Dec; 17(4):491-6. PubMed ID: 10089073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.
    Kawesha A; Ghaneh P; Andrén-Sandberg A; Ograed D; Skar R; Dawiskiba S; Evans JD; Campbell F; Lemoine N; Neoptolemos JP
    Int J Cancer; 2000 Nov; 89(6):469-74. PubMed ID: 11102889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Study on the relation between the cell cycle regulators and laryngeal carcinogenesis].
    Wang J; Lou W; Dong M
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Mar; 15(3):112-4. PubMed ID: 12541678
    [TBL] [Abstract][Full Text] [Related]  

  • 79. p21(Waf1/Cip1) and p53 protein expression in breast cancer.
    Wakasugi E; Kobayashi T; Tamaki Y; Ito Y; Miyashiro I; Komoike Y; Takeda T; Shin E; Takatsuka Y; Kikkawa N; Monden T; Monden M
    Am J Clin Pathol; 1997 Jun; 107(6):684-91. PubMed ID: 9169666
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A clinicopathological study of p53, p21 (WAF1/CIP1) and cyclin D1 expression in human prostate cancers.
    Shiraishi T; Watanabe M; Muneyuki T; Nakayama T; Morita J; Ito H; Kotake T; Yatani R
    Urol Int; 1998; 61(2):90-4. PubMed ID: 9873247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.